ImmunityBio, Inc. (IBRX)
7.44
-0.75
(-9.16%)
USD |
NASDAQ |
Apr 24, 16:00
7.49
+0.05
(+0.67%)
After-Hours: 20:00
ImmunityBio Shareholders Equity (Quarterly) : -500.47M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 52.61B |
| ANI Pharmaceuticals, Inc. | 540.72M |
| Gilead Sciences, Inc. | 22.70B |
| Eli Lilly & Co. | 26.54B |
| Arcellx, Inc. | 402.35M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 501.90M |
| Total Liabilities (Quarterly) | 1.001B |
| Debt to Equity Ratio | -1.688 |
| Current Ratio | 5.099 |
| Net Debt Paydown Yield | 1.74% |